Uproleselan
- Generic Name
- Uproleselan
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C60H109N3O27
- CAS Number
- 1983970-12-2
- Unique Ingredient Identifier
- PE952ANF83
- Background
Uproleselan is a novel, specific E-Selectin antagonist under investigation in clinical trial NCT02306291 (Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML).
- Associated Conditions
- -
- Associated Therapies
- -
A Study in Healthy Volunteers to Investigate How Much Test Medicine [14C]-Uproleselan is Taken up by the Body When Administered Directly Into the Vein (IV)
- First Posted Date
- 2018-07-30
- Last Posted Date
- 2019-05-14
- Lead Sponsor
- GlycoMimetics Incorporated
- Target Recruit Count
- 5
- Registration Number
- NCT03606447
- Locations
- 🇬🇧
Quotient Sciences Limited, Ruddington, Nottingham, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath